Dr. Peter A. Kaufman
Claim this profileUniversity of Vermont Medical Center
Area of expertise
Breast Cancer
Peter A. Kaufman has run 8 trials for Breast Cancer. Some of their research focus areas include:
Cancer
Peter A. Kaufman has run 3 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
The University Of Vermont Medical Center Inc.
University Of Vermont Medical Center
Clinical Trials Peter A. Kaufman is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting
2 awards
Phase 3
12 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
More about Peter A. Kaufman
Clinical Trial Related
2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Peter A. Kaufman has experience with
- Abemaciclib
- Fulvestrant
- Imlunestrant
- Exemestane
- LY3484356
- Lasofoxifene
Breakdown of trials Peter A. Kaufman has run
Breast Cancer
Cancer
Pancreatic Cancer
Endometrial Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter A. Kaufman specialize in?
Peter A. Kaufman focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Peter A. Kaufman currently recruiting for clinical trials?
Yes, Peter A. Kaufman is currently recruiting for 3 clinical trials in Burlington Vermont. If you're interested in participating, you should apply.
Are there any treatments that Peter A. Kaufman has studied deeply?
Yes, Peter A. Kaufman has studied treatments such as Abemaciclib, Fulvestrant, Imlunestrant.
What is the best way to schedule an appointment with Peter A. Kaufman?
Apply for one of the trials that Peter A. Kaufman is conducting.
What is the office address of Peter A. Kaufman?
The office of Peter A. Kaufman is located at: University of Vermont Medical Center, Burlington, Vermont 05401 United States. This is the address for their practice at the University of Vermont Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.